January 31, 2013 at 11:19 AM EST
Novo Nordisk Stock Hits High After Q4 Profit Beat
Shares of Danish diabetes giant Novo Nordisk (NVO) hit a new high early Thursday after the company beat Q4 estimates and raised its margin target. Net income in the quarter rose 23% over the prior year's quarter to 5.76 billion kroner, or $1.1 billion, beating the Bloomberg consensus estimate of 5.34 billion kroner. Sales rose 16% to 20.96 billion kroner, or $3.8 billion. The company said it's expecting sales growth of 8% to 11% this year, in line
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here